J9201 Gemcitabine - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Gemcitabine

Brand Name:

Gemzar

Strength:

200 mg

HCPCS:

J9201

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Pyrimidine Analog

Oral (Y/N):

No

FDA Approval Year:

1996

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 1998

CMS Discontinuation Date:

Status:

In Use